City of Hope Advances CAR T Cell Therapy with Plug-and-Play Technology
Researchers from City of Hope have developed a new 'plug-and-play' technology that allows for more flexible and adaptive CAR T cell therapy, targeting different types of cancer as they mutate. This innovation, published in Cancer Immunology Research, enhances control over engineered molecules in CAR T cells, offering a promising approach to outpace evolving tumor types in patients.